A study to evaluate whether the reduced calcineurin inhibitor exposure early after liver transplantation protects against renal dysfunction independently of the use of basiliximab induction therapy.
Phase of Trial: Phase IV
Latest Information Update: 12 Aug 2015
At a glance
- Drugs Basiliximab (Primary) ; Tacrolimus
- Indications Liver transplant rejection; Renal impairment
- Focus Therapeutic Use
- 12 Aug 2015 New trial record